Skip to main content
Log in

Modifying a bacterial tyrosinase zymogen for use in protease activity assays

  • Methods and Protocols
  • Published:
Applied Microbiology and Biotechnology Aims and scope Submit manuscript

Abstract

Current clinical laboratory assays are not sufficient for determining the activity of many specific human proteases yet. In this study, we developed a general approach that enables the determination of activities of caspase-3 based on the proteolytic activation of the engineered zymogen of the recombinant tyrosinase from Verrucomicrobium spinosum (Vs-tyrosinase) by detecting the diphenolase activity in an increase in absorbance at 475 nm. Here, we designed three different zymogen constructs of Vs-tyrosinase, including RSL-pre-pro-TYR, Pre-pro-TYR, and Pro-TYR. The active domain was fused to the reactive site loop (RSL) of α1-proteinase inhibitor and/or its own signal peptide (pre) and/or its own C-terminal domain (pro) via a linker containing a specific caspase-3 cleavage site. Further studies revealed that both RSL peptide and TAT signal peptide were able to inhibit tyrosinase diphenolase activity, in which RSL-pre-pro-TYR had the lowest background signals. Therefore, a specific protease activity such as caspase-3 could be detected when a suitable zymogen was established. Our results could provide a new way to directly detect the activities of key human proteases, for instance, to monitor the efficacy and safety of tumor therapy by determining the activity of apoptosis-related caspase-3 in patients.

Key points

RSL inhibited the activity of Verrucomicrobium spinosum tyrosinase.

N-pre and C-terminal domain exerted stronger dual inhibition on the Vs-tyrosinase.

The activity of caspase-3 could be measured by the zymogen activation system.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The datasets generated and/or analyzed during this study are included in this manuscript (and its supplementary information file). Any additional data, if needed, will be available with the corresponding author upon reasonable request.

References

Download references

Acknowledgements

We are grateful to Professor Fei Xiao for his valuable suggestions on the experimental design. We are grateful to Professor Meng Wang for his valuable suggestions on the enzymatic activity analysis.

Funding

This study was funded by Beijing Hospital Project BJ-2020–134 and the National Natural Science Foundation of China (81871107).

Author information

Authors and Affiliations

Authors

Contributions

JZ and LZ conceived and designed research. JZ, WH, LZ, and XT conducted experiments. JZ and GS analyzed data. JZ and LZ wrote the manuscript. All authors read and approved the manuscript.

Corresponding author

Correspondence to Lihui Zou.

Ethics declarations

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 272 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, J., Huang, W., Zhang, L. et al. Modifying a bacterial tyrosinase zymogen for use in protease activity assays. Appl Microbiol Biotechnol 106, 8285–8294 (2022). https://doi.org/10.1007/s00253-022-12284-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00253-022-12284-4

Keywords

Navigation